Brenton Flynn

Brenton Flynn


Recent articles

MAKO Provides a Sneak Peek

We get to see some key metrics from MAKO's Q4 before the company officially releases earnings.

What Should You Think of the New Abbott Labs?

Now that Abbott Labs has slimmed down and lost its branded pharmaceuticals division by spinning off the new AbbVie, what should investors make of it?